Zenas BioPharma, Inc.
ZBIO
$32.53
-$0.52-1.57%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -10.33% | 108.98% | 17.98% | 6.44% | -12.52% |
| Total Receivables | -27.27% | -8.33% | -7.69% | 0.00% | -23.53% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -16.79% | 74.94% | 52.06% | 10.79% | 7.94% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -10.46% | 107.92% | 18.38% | 6.47% | -12.34% |
|
|
|||||
| Total Current Assets | -10.46% | 107.92% | 18.38% | 6.47% | -12.34% |
| Net Property, Plant & Equipment | -24.51% | -19.45% | 61.96% | -19.98% | -16.07% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.16% | 9.06% | 0.05% | 17.00% | -8.18% |
| Total Assets | -6.15% | 94.89% | 19.14% | 9.87% | -12.19% |
|
|
|||||
| Total Accounts Payable | -15.15% | 25.78% | 10.35% | -18.75% | -60.38% |
| Total Accrued Expenses | 12.42% | -5.97% | 19.72% | 1.88% | 57.87% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -20.64% | -7.00% | 80.42% | -22.07% | -12.67% |
| Total Finance Division Other Current Liabilities | -- | 0.00% | -- | -- | -- |
| Total Other Current Liabilities | -- | 0.00% | -- | -- | -- |
| Total Current Liabilities | 7.61% | -2.38% | 19.51% | -1.55% | 8.37% |
|
|
|||||
| Total Current Liabilities | 7.61% | -2.38% | 19.51% | -1.55% | 8.37% |
| Long-Term Debt | 11.78% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -71.43% | -63.51% | 17.22% | -16.28% | -32.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.05% | 7.97% | 7.74% | -- | -- |
| Total Liabilities | 10.38% | 191.07% | 12.67% | 134.93% | 8.11% |
|
|
|||||
| Common Stock & APIC | 1.99% | 17.37% | 39.68% | 1.16% | 1.10% |
| Retained Earnings | -13.17% | -10.58% | -45.83% | -10.88% | -12.41% |
| Treasury Stock & Other | -202.65% | -489.06% | 7.25% | 26.60% | -166.67% |
| Total Common Equity | -26.42% | 38.69% | 23.27% | -18.03% | -15.72% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -26.42% | 38.69% | 23.27% | -18.03% | -15.72% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -26.42% | 38.69% | 23.27% | -18.03% | -15.72% |
|
|
|||||